Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12060350
Therapeutic compounds and methods of use thereof
granted -
US 12060327
Psychotropic agents and uses thereof
granted -
US 12059471
Complex
granted -
US 12059474
Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins
granted -
US 12059437
Methods and compositions for hematopoietic stem cell mobilization
granted -
US 12060419
CD79A chimeric antigen receptors
granted -
US 12060346
Inhibitors of APOL1 and methods of using same
granted -
US 12059407
Compositions and methods for delivery of macromolecules
granted -
US 12059477
Nanomaterials
granted -
US 12059413
Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction
granted -
US 12059214
System and method of performing treatment along a lumen network
granted -
US 12060398
Fibrous proteinaceous networks and methods of use thereof
granted -
US 12059400
Medical compound
granted -
WO 2024162304
LIPIDE CARBAMOYLE OU LIPIDE D'URΓE AYANT CHACUN UNE AMINE CYCLIQUE, NANOPARTICULES LIPIDIQUES LE CONTENANT ET COMPOSITION PHARMACEUTIQUE
granted -
US 12054519
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
granted -
US 12053534
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
granted -
US 12054493
Hepatitis B antiviral agents
granted -
US 12054556
Anti-PD-L1 antibody and use thereof
granted -
US 12054533
Anti-VEGF protein compositions and methods for producing the same
granted -
US 12054509
Antimicrobial compounds, compositions, and uses thereof
granted -
US 12054501
Compositions and methods for inhibiting arginase activity
granted -
US 12054500
Arginase inhibitors
granted -
US 12054749
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
granted -
US 12054537
Optimized nucleic acid antibody constructs encoding anti-respiratory syncytial virus (RSV) antibodies
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.